PCRS Logo

 

The Primary Care Respiratory Society

Inspiring best practice in respiratory care

 Facebook LogoTwitter Logo

This website is for healthcare professionals only

GINA publishes 2019 asthma guidance updates

The Global Initiative for Asthma (GINA) has released a 2019 update to their Pocket Guide for Asthma Management and Prevention and the Pocket Guide on Diagnosis and Management of Difficult-to-treat and Severe Asthma in adolescent and adult patients.

The key changes are:

  • For safety, GINA no longer recommends starting treatment of asthma with short-acting beta2-agonist (SABA) reliever inhalers on their own. Instead all adults and adolescents with asthma should receive either symptom-driven (for mild asthma) or daily inhaled anti-inflammatory controller treatment, to reduce their risk of serious exacerbations and to control symptoms.
  • The updated recommendations for severe asthma include additions to the treatment algorithm for severe asthma, including the availability of an additional biologic treatment (dupilumab, an antibody against interleukin-4 receptor alpha), and advice about extension of a treatment trial of biologic therapy to 6-12 months if the initial response is unclear.

PCRS Executive Chair Dr Noel Baxter says: “This is a helpful review of the latest evidence. The GINA recommendation that the first step for treating asthma is to treat inflammation is not dissimilar to the BTS/SIGN position which PCRS supports.

“However it is important to remember that SABA does still have important value in COPD and in emergency therapy

Category: 
News
Derivation: 
PCRS Produced / Collaboration
Clinical Area: 
Asthma
Listing Status: 
Current